Payers Using Two Approaches To Price Molecular, Genetic Tests

PRIVATE PAYERS AND MEDICARE contractors are taking divergent approaches to establishing coverage policies and setting prices for molecular and genetic tests. That’s what Kuo Bianchini Tong, MS, CEO of Quorum Consulting Inc., sees happening. “One approach seeks to recognize the clinical utility and value of these tests with nuanced, more discreet coding and pricing,” he …

Payers Using Two Approaches To Price Molecular, Genetic Tests Read More »

To access this post, you must purchase The Dark Report.

Payers Using Two Approaches To Price Molecular, Genetic Tests

One is nuanced, sophisticated, the other is more about lower prices for genetic tests

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month